Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: An in vivo study in mice

Neuroscience

Volumn 82, Issue 2, 1997, Pages 521-528

  Zocchi, A ^a,b   Orsini, C ^a   Cabib, S ^b   Puglisi Allegra, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

Author keywords

Amphetamine; C57BL ; DBA 2; Dopamine; Microdialysis; Nucleus accumbens

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; DOPAMINE; HOMOVANILLIC ACID; PSYCHOSTIMULANT AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ABUSE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; INBRED STRAIN; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; QUANTITATIVE TRAIT;

EID: 0342894819     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00276-5     Document Type: Article

References (47)

1. Ackerman J. M., White F. J. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117:1990;181-187.
2. Anisman H., Cygan D. Central effects of scopolamine and (+)-amphetamine on locomotor activity: interaction with strain and stress variables. Neuropharmacology. 14:1975;835-840.
3. Anisman H., Wahlstein D., Kokkinidis L. Effects of D-amphetamine and scopolamine before and after shock in three mouse strains. Pharmac. Biochem. Behav. 3:1975;819-824.
4. Badiani A., Cabib S., Puglisi-Allegra S. Chronic stress induces strain-dependent sensitization to the behavioral effects of amphetamine in the mouse. Pharmac. Biochem. Behav. 43:1992;53-60.
5. Belknap J. K., Buck K. J. Genetic animal models of alcohol and drug abuse. Science. 264:1994;1715-1723.
6. Belknap J. K. and O'Toole L. A. (1991) Studies in genetic differences in response to opioid drugs. In The Genetic Basis of Alcohol and Drug Actions (eds Crabbe J. C. and Harris R. A.), pp. 225-252. Plenum, New York.
7. Cabib S. Strain-dependent behavioural sensitization to amphetamine: role of environmental factors. Behav. Pharmac. 4:1993;367-374.
8. Cabib S., Bonaventura N. Parallel strain-dependent susceptibility for environmentally-induced stereotypies and stress-induced behavioral sensitization. Physiol. Behav. 61:1997;499-506.
9. Cabib S., Castellano C., Patacchioli F. R., Cigliana G., Angelucci L., Puglisi-Allegra S. Opposite effects of post-training corticosterone on memory storage in mice: role of dopamine. Brain Res. 729:1996;110-118.
10. Cabib S., Puglisi-Allegra S. Genotype-dependent effects of chronic stress on striatal and mesolimbic dopamine metabolism in response to apomorphine. Brain Res. 542:1991;91-96.
11. Cabib S., Zocchi A., Puglisi-Allegra S. A comparison of the behavioral effects of minaprine, amphetamine and stress. Psychopharmacology. 121:1995;73-80.
12. Commissioning J. W. Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity. Biochem. Pharmac. 34:1985;1127-1131.
13. Crabbe J. C., Belknap J. K., Buck K. J. Genetic animal models of alcohol and drug abuse. Science. 264:1994;1715-1723.
14. Creese I., Iversen S. D. The pharmacological and anatomical substrate of the amphetamine response in the rat. Brain Res. 83:1975;419-436.
15. Cunningham C. L. Localization of genes influencing ethanol-induced conditioned place preference and locomotor activity in BXD recombinant inbred mice. Psychopharmacology. 120:1995;28-41.
16. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc. natn. Acad. Sci. U.S.A. 85:1988;5274-5278.
17. Filibeck U., Castellano C., Oliverio A. Development of morphine-induced changes of activity in the mouse. Devl Brain Res. 2:1982;602-605.
18. Giros B., Jaber M., Jones S. R., Wightman R. M., Caron M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
19. Gora-Maslak G., McClearn G. E., Crabbe J. C., Phillips T. J., Belknap J. K., Plomin R. Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology. Psychopharmacology. 104:1991;413-424.
20. Hooks M. S., Jones G. H., Smith A. D., Neill D. B., Justice J. B. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse. 91:1991;121-128.
21. Imperato A., Obinu M. C., Mascia M. S., Casu M. A., Zocchi A., Cabib S., Puglisi-Allegra S. Strain-dependent effects of dopamine agonists on acetylcholine release in the hippocampus: an in vivo study in mice. Neuroscience. 70:1996;653-660.
22. Kalivas P. W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J. Neurosci. 13:1993;276-284.
23. Kilpatrick G. J., Hagan R. M., Gale J. D. 5HT3 and 5HT4 receptors in terminal regions of the mesolimbic system. Behav. Brain Res. 73:1995;10-12.
24. Koff J. M., Shuster L., Miller L. G. Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J. Pharmac. exp. Ther. 268:1994;277-282.
25. Kuczenski R., Segal D. S. Differential effects of amphetamine and dopamine uptake blockers (Cocaine, Nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmac. exp. Ther. 262:1992;1085-1094.
26. Kuczenski R., Segal D. S., Ch A. K., Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15:1995;1308-1317.
27. Mylecharane E. J. Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioral studies. Behav. Brain Res. 73:1996;1-5.
28. O'Brien C. P., Ehrman A. R. and Terns J. N. (1986) Classical conditioning in human opioid dependence. In Behavioral Analysis of Drug Dependence (eds Goldberg S. R. and Stolerman I. P.), p. 329. Academic, London.
29. Phillips T. J., Dickinson S., Burkhart-Kasch S. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav. Neurosci. 108:1994;789-803.
30. Piazza P. V., Deminiere J. M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
31. Piazza P. V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids and dopaminergic neurons. A. Rev. Pharmac. Toxic. 36:1996;359-378.
32. Plomin R. The role of inheritance in behavior. Science. 183:1990;183-188.
33. Puglisi-Allegra S., Cabib S. Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice. Prog. Neurobiol. 51:1997;637-661.
34. 3H-SCH23390 in different brain areas of inbred strains of mice. In 24th Meeting of the Society for Neuroscience, Abstr. No. 377.16.
35. Robinson T. E., Berridge K. C. The neural basis of drug craving: an incentive motivation theory of addiction. Brain Res. Rev. 18:1993;247-292.
36. Robinson T. E., Jurson P. A., Bennet J. A., Bentgen K. M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462:1988;211-222.
37. Sidman R. L., Angevine J. B. Jr and Pierce E. T. (1971) Atlas of the Mouse Brain and Spinal Cord. Harvard University Press, Cambridge, MA.
38. Sorg B. A., Kalivas P. W. Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res. 559:1991;92-96.
39. Stevens K. E., Mickley G. A., McDermot L. J. Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse. Pharmac. Biochem. Behav. 24:1986;1739-1747.
40. Teitelbaum H., Giammatteo P., Mickley G. A. Differential effects of localized lesions of n. accumbens on morphine- and amphetamine-induced locomotor hyperactivity in the C57BL/6J. J. comp. physiol. Psychol. 93:1979;745-751.
41. Tricklebank M. D. The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine system. Behav. Brain Res. 73:1996;15-17.
42. Vezina P. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 605:1993;332-337.
43. Wang R. Y., Ashby C. R., Zhang J. Y. Modulation of the A10 dopamine system: electrophysiological studies of the role of 5HT3-like receptors. Behav. Brain Res. 73:1996;6-9.
44. Wenger G. R. (1979) Some quantitative behavioral pharmacology in the mouse. In Advances in Behavioral Pharmacology (eds Thompson T. and Dews P. B.), Vol. 2, pp. 1-38. Academic, London.
45. Wilkinson L. S., Mittleman G., Torres E., Humby T., Hall F. S., Robbins T. W. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus. Behav. Brain Res. 55:1993;143-150.
46. Wolf M. E., White F. J., Nassar R., Brooderson R. J., Khansa M. R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmac. exp. Ther. 264:1993;149-255.
47. Womer D. E., Jones B. C., Erwin V. G. Characterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, Epidepride, and SCH 23390 in C57BL and DBA mice. Pharmac. Biochem. Behav. 48:1994;327-335.